Spotlight

Biotech

Anna Gluskin, CEO of Eastgate BioTech (OTC: ETBI) discusses positive results and how they are ready to take the Insulin market by storm.

May 2, 2019 The Wall Street Analyzer Comments Off on Anna Gluskin, CEO of Eastgate BioTech (OTC: ETBI) discusses positive results and how they are ready to take the Insulin market by storm.

“We’re doing a number of trials in Pakistan right now and the results that we announced just the other day; the end of the month, we’re showing a very good efficacy in absorption of product without injection.” […]

Biotech

Citius Provides Update on Its CITI Platforms and Gives Investors Further Insight on their Licensing Agreement with MD Anderson Cancer Center

January 17, 2019 The Wall Street Analyzer Comments Off on Citius Provides Update on Its CITI Platforms and Gives Investors Further Insight on their Licensing Agreement with MD Anderson Cancer Center

Citius Pharmaceuticals (NASDAQ: CTXR) CEO: Myron Holubiak About: Citius Pharmaceuticals (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for large and growing markets. Citius products offer new and […]

No Picture
Spotlight

The Wall Street Analyzer recently interviewed David D’Onofrio, the CEO of White Gold Corporation (TSX.V: WGO) (US OTC – NASDAQ International: WHGOF) to discuss the company’s recent impressive drill results at their new Vertigo discovery on their JP Ross Property, located in the Yukon territory.

November 20, 2018 The Wall Street Analyzer Comments Off on The Wall Street Analyzer recently interviewed David D’Onofrio, the CEO of White Gold Corporation (TSX.V: WGO) (US OTC – NASDAQ International: WHGOF) to discuss the company’s recent impressive drill results at their new Vertigo discovery on their JP Ross Property, located in the Yukon territory.

  The Wall Street Analyzer recently interviewed David D’Onofrio, the CEO of White Gold Corporation (TSX.V: WGO) (US OTC – NASDAQ International: WHGOF) to discuss the company’s recent impressive drill results at their new Vertigo […]

CEO Interviews

AmeraMex (OTC: AMMX) Interview update with CEO Lee Hamree covering the companies’ recent orders and upcoming goals.

October 3, 2018 The Wall Street Analyzer Comments Off on AmeraMex (OTC: AMMX) Interview update with CEO Lee Hamree covering the companies’ recent orders and upcoming goals.

“Over the last three years we have increased our rental fleet from $2 million to approximately $9 million. A couple years ago, I predicted the value of our rental fleet was going to $10 million by the end of 2018. And we are coming up on the end of 2018, and we are right at $9 million in total value in the rental fleet. ” […]

CEO Interviews

Contravir (NASDAQ: CTRV) Interview with CEO James Sapirstein in which he discusses recent funding and CRV431 progress

July 9, 2018 The Wall Street Analyzer Comments Off on Contravir (NASDAQ: CTRV) Interview with CEO James Sapirstein in which he discusses recent funding and CRV431 progress

Contravir Pharmaceuticals (NASDAQ: CTRV) CEO: James Sapirstein   INTERVIEW TRANSCRIPTS: WSA:  Good day from Wall Street, this is Juan Costello Senior Analyst with the Wall Street Analyzer. Joining us today is James Sapirstein CEO for […]

CEO Interviews

Generation Next Franchise Brands (OTC: VEND) Interview with Chairman Nick Yates and CEO Arthur Budman

July 5, 2018 The Wall Street Analyzer Comments Off on Generation Next Franchise Brands (OTC: VEND) Interview with Chairman Nick Yates and CEO Arthur Budman

Generation Next Franchise Brands (OTC: VEND) Chairman: Nick Yates CEO: Arthur Budman About: Generation NEXT Franchise Brands, Inc., based in San Diego, California, is a publicly traded company on the OTC Markets trading under the symbol […]